Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Retained Earnings (2020 - 2026)

Design Therapeutics' Retained Earnings history spans 2 years, with the latest figure at -$244000.0 for Q4 2021.

  • On a quarterly basis, Retained Earnings fell 256.41% to -$244000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$244000.0, a 256.41% decrease, with the full-year FY2021 number at -$244000.0, down 256.41% from a year prior.
  • Retained Earnings hit -$244000.0 in Q4 2021 for Design Therapeutics, down from -$4000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for DSGN hit a ceiling of $156000.0 in Q4 2020 and a floor of -$244000.0 in Q4 2021.